When COPD and Type 2 Diabetes Co-exist – Risks, Management and Challenges
January 28, 2026 @ 7:30 pm – 9:00 pm
This session examines type 2 diabetes as a major co-morbidity in people with COPD, focusing on the bidirectional impact each condition has on morbidity, mortality, and quality of life.
We’ll explore shared risk factors, the role of systemic inflammation, and how COPD treatments—particularly corticosteroids—affect glycaemic control.
The session will provide practical, primary-care-focused guidance on conducting holistic reviews, adjusting diabetes therapy in patients with respiratory disease, preventing exacerbations, and minimising treatment burden.
Case-based discussions will highlight real-world strategies for coordinating care, supporting self-management, and reducing unplanned admissions.
Speaker: Tracey Kirk – Director of Education at the Primary Care Respiratory Training Centre and the Primary Care Diabetes Training Centre.
